These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

270 related articles for article (PubMed ID: 19170707)

  • 1. Functional analysis of two rare CYP21A2 mutations detected in Italian patients with a mildest form of congenital adrenal hyperplasia.
    Concolino P; Vendittelli F; Mello E; Minucci A; Carrozza C; Rossodivita A; Giardina B; Zuppi C; Capoluongo E
    Clin Endocrinol (Oxf); 2009 Oct; 71(4):470-6. PubMed ID: 19170707
    [TBL] [Abstract][Full Text] [Related]  

  • 2. p.H282N and p.Y191H: 2 novel CYP21A2 mutations in Italian congenital adrenal hyperplasia patients.
    Concolino P; Mello E; Patrosso MC; Penco S; Zuppi C; Capoluongo E
    Metabolism; 2012 Apr; 61(4):519-24. PubMed ID: 22014889
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Functional and structural analysis of four novel mutations of CYP21A2 gene in Italian patients with 21-hydroxylase deficiency.
    Massimi A; Malaponti M; Federici L; Vinciguerra D; Manca Bitti ML; Vottero A; Ghizzoni L; Maccarrone M; Cappa M; Bernardini S; Porzio O
    Horm Metab Res; 2014 Jun; 46(7):515-20. PubMed ID: 24799024
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CYP21A2 intronic variants causing 21-hydroxylase deficiency.
    Concolino P; Rizza R; Costella A; Carrozza C; Zuppi C; Capoluongo E
    Metabolism; 2017 Jun; 71():46-51. PubMed ID: 28521877
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Two novel CYP21A2 missense mutations in Italian patients with 21-hydroxylase deficiency: Identification and functional characterisation.
    Concolino P; Vendittelli F; Mello E; Carelli Alinovi C; Minucci A; Carrozza C; Santini SA; Zuppi C; Capoluongo E
    IUBMB Life; 2009 Mar; 61(3):229-35. PubMed ID: 19152428
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Three novel CYP21A2 mutations and their protein modelling in patients with classical 21-hydroxylase deficiency from northeastern Iran.
    Baradaran-Heravi A; Vakili R; Robins T; Carlsson J; Ghaemi N; A'rabi A; Abbaszadegan MR
    Clin Endocrinol (Oxf); 2007 Sep; 67(3):335-41. PubMed ID: 17573904
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Investigation of CYP21A2 mutations in Turkish patients with 21-hydroxylase deficiency and a novel founder mutation.
    Toraman B; Ökten A; Kalay E; Karagüzel G; Dinçer T; Açıkgöz EG; Karagüzel A
    Gene; 2013 Jan; 513(1):202-8. PubMed ID: 23142378
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Four novel missense mutations in the CYP21A2 gene detected in Russian patients suffering from the classical form of congenital adrenal hyperplasia: identification, functional characterization, and structural analysis.
    Grischuk Y; Rubtsov P; Riepe FG; Grötzinger J; Beljelarskaia S; Prassolov V; Kalintchenko N; Semitcheva T; Peterkova V; Tiulpakov A; Sippell WG; Krone N
    J Clin Endocrinol Metab; 2006 Dec; 91(12):4976-80. PubMed ID: 16984992
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rare mutations in the CYP21A2 gene detected in congenital adrenal hyperplasia.
    Neocleous V; Ioannou YS; Bartsota M; Costi C; Skordis N; Phylactou LA
    Clin Biochem; 2009 Sep; 42(13-14):1363-7. PubMed ID: 19501079
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A new CYP21A1P/CYP21A2 chimeric gene identified in an Italian woman suffering from classical congenital adrenal hyperplasia form.
    Concolino P; Mello E; Minucci A; Giardina E; Zuppi C; Toscano V; Capoluongo E
    BMC Med Genet; 2009 Jul; 10():72. PubMed ID: 19624807
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CYP21A2 p.E238 deletion as result of multiple microconversion events: a genetic study on an Italian congenital adrenal hyperplasia (CAH) family.
    Concolino P; Mello E; Zuppi C; Toscano V; Capoluongo E
    Diagn Mol Pathol; 2013 Mar; 22(1):48-51. PubMed ID: 23370425
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A new CYP21A2 nonsense mutation causing severe 21-hydroxylase deficiency.
    Concolino P; Minucci A; Mello E; Zuppi C; Capoluongo E
    Clin Chem Lab Med; 2009; 47(7):824-5. PubMed ID: 19499972
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Three novel point mutations of the CYP21 gene detected in classical forms of congenital adrenal hyperplasia due to 21-hydroxylase deficiency.
    Krone N; Riepe FG; Partsch CJ; Vorhoff W; Brämswig J; Sippell WG
    Exp Clin Endocrinol Diabetes; 2006 Mar; 114(3):111-7. PubMed ID: 16636976
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High-resolution melting curve (HRM) analysis to establish CYP21A2 mutations converted from the CYP21A1P in congenital adrenal hyperplasia.
    Lin YC; Lin YC; Liu TC; Chang JG; Lee HH
    Clin Chim Acta; 2011 Oct; 412(21-22):1918-23. PubMed ID: 21762683
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Novel non-classic CYP21A2 variants, including combined alleles, identified in patients with congenital adrenal hyperplasia.
    Karlsson L; de Paula Michelatto D; Lusa ALG; D'Almeida Mgnani Silva C; Östberg LJ; Persson B; Guerra-Júnior G; Valente de Lemos-Marini SH; Baldazzi L; Menabó S; Balsamo A; Greggio NA; Palandi de Mello M; Barbaro M; Lajic S
    Clin Biochem; 2019 Nov; 73():50-56. PubMed ID: 31344365
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A rare CYP21A2 haplotype clarifies the phenotype-genotype discrepancy in an Italian patient with Non Classical Congenital Adrenal Hyperplasia (NC-CAH).
    Concolino P
    Mol Biol Rep; 2020 Apr; 47(4):3049-3052. PubMed ID: 32185686
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vitro functional studies of rare CYP21A2 mutations and establishment of an activity gradient for nonclassic mutations improve phenotype predictions in congenital adrenal hyperplasia.
    Barbaro M; Soardi FC; Östberg LJ; Persson B; de Mello MP; Wedell A; Lajic S
    Clin Endocrinol (Oxf); 2015 Jan; 82(1):37-44. PubMed ID: 24953648
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Application of the DHPLC method for mutational detection of the CYP21A2 gene in congenital adrenal hyperplasia.
    Tsai LP; Cheng CF; Hsieh JP; Teng MS; Lee HH
    Clin Chim Acta; 2009 Dec; 410(1-2):48-53. PubMed ID: 19778530
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular genetic study of congenital adrenal hyperplasia in Serbia: novel p.Leu129Pro and p.Ser165Pro CYP21A2 gene mutations.
    Milacic I; Barac M; Milenkovic T; Ugrin M; Klaassen K; Skakic A; Jesic M; Joksic I; Mitrovic K; Todorovic S; Vujovic S; Pavlovic S; Stojiljkovic M
    J Endocrinol Invest; 2015 Nov; 38(11):1199-210. PubMed ID: 26233337
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular diagnosis of congenital adrenal hyperplasia due to 21-hydroxylase deficiency: an update of new CYP21A2 mutations.
    Concolino P; Mello E; Zuppi C; Capoluongo E
    Clin Chem Lab Med; 2010 Aug; 48(8):1057-62. PubMed ID: 20482300
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.